DanielWaldenMD

Hematology/Oncology

Physician

Dr. Walden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology, 2021 - 2023
Mayo Clinic College of Medicine and Science (Scottsdale)Residency, Internal Medicine, 2018 - 2021
Medical College of WisconsinClass of 2018
University of WisconsinBS, Microbiology/Immunology and Psychology, Cum Laude

PubMed

2 citations
Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis.
Daniel Walden, Mohamad Bassam Sonbol, Skye A. Buckner Petty, Harry H. Yoon, Mitesh J. Borad
Frontiers in Oncology. 2021-09-10
17 citations
A Systematic Review and Network Meta‐Analysis of Regorafenib and TAS‐102 in Refractory Metastatic Colorectal Cancer
Mohamad Bassam Sonbol, Raed Benkhadra, Zhen Wang, Belal Firwana, Daniel Walden
The Oncologist. 2019-09-01
18 citations
Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma.
Daniel Walden, Selvi Kunnimalaiyaan, Kevin M. Sokolowski, T. Clark Gamblin, Muthusamy Kunnimalaiyaan
Oncotarget. 2017-10-01

Abstracts/Posters

A retrospective analysis of maintenance strategies in metastatic gastric and gastroesophageal cancer
Walden, Daniel & Sonbol, Bassam & Borad, M. & Petty, S. & Yoon, H. & Bekaii-Saab, Tanios & Ahn, D, Annals of Oncology

Lectures

Continuous fluropyrimidine (FP) with platinum (P) based chemotherapy (CT) versus maintenance FP after induction therapy in advanced gastric (G) and gastroesophageal (G...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020

Shorter Courses of Chemo Treatment Taking Hold in Colon CancerFebruary 11th, 2022